Jacques Gilloteaux

Title: The Innovative Contributions of Jacques Gilloteaux

Introduction

Jacques Gilloteaux is a notable inventor based in Kent, OH (US). He has made significant contributions to the field of cancer treatment through his innovative patent. His work focuses on the combination of Vitamin C and a quinone, which serves as a supplemental treatment for cancer patients.

Latest Patents

Gilloteaux holds a patent for a unique combination of Vitamin C and a quinone. This combination is designed to be administered before, during, and after conventional cancer treatment protocols. The treatment can be given orally, intravenously, or intraperitoneally. Oral administration may involve capsules containing a specific ratio of Vitamin C to Vitamin K. This supplemental treatment is effective in inhibiting metastases of cancer cells and tumor growth. The optimal ratio of Vitamin C to Vitamin K ranges from about 50 to 1 to about 250 to 1. Additionally, a method for evaluating the treatment's effectiveness includes monitoring the patient's serum DNase activity throughout the treatment course.

Career Highlights

Gilloteaux is associated with Summa Health System, where he continues to contribute to advancements in medical treatments. His innovative approach to cancer therapy showcases his dedication to improving patient outcomes.

Collaborations

Some of his notable coworkers include Henryk S Taper and James M Jamison, who have likely collaborated with him on various projects within the healthcare sector.

Conclusion

Jacques Gilloteaux's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patent reflects a commitment to enhancing therapeutic options for patients, showcasing the importance of research and development in healthcare.